When launching and commercialising a new drug or remedy for market, there is often a lack of sufficient evidence and strong statistical insight to support the planning and preparation process. Such poor practice often generates poor results, misguided insight and avoidable business errors across multiple stages of the launch process.
As Statisticians, we work on the front lines of clinical data, using statistical analysis to find meaningful evidence and insight that can help make informed clinical and business decisions. However, even when delivering clinical study reports and submission documents, the resulting publications can often lack an in-depth statistical review.
In this webinar you will learn about how statistical evidence flows through organisations from its origin to physicians, payers, and patients. Discover which parts of the information flow can trigger lower quality, and how to influence these areas to ensure that the quality of evidence is retained up to the final external customer.